AAV9-Follistatin Gene Therapy

AAV9-Follistatin gene therapy involves using an adeno-associated virus (AAV9) vector to deliver the follistatin gene into cells. Follistatin is a protein that inhibits myostatin, a growth factor that limits muscle growth. This therapy aims to enhance muscle mass and strength, which could be beneficial for age-related muscle loss and other muscle-wasting conditions, contributing to improved longevity and healthspan.